More articles from Article

You have access
Analgesic α-Conotoxin Binding Site on the Human GABA_B Receptor
Anuja R. Bony, Jeffrey R. McArthur, Akari Komori, Ann R. Wong, Andrew Hung and David J. Adams

Molecular Pharmacology October 2022, 102 (4) 196-208; DOI: https://doi.org/10.1124/molpharm.122.000543
You have access
Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial Leads
Michelle M. Butler, Samanthi L. Waidyarachchi, Jinfeng Shao, Son T. Nguyen, Xiaoyuan Ding, Steven C. Cardinale, Lucas R. Morin, Steven M. Kwasny, Mai Ito, Jeanine Gezelle, María B. Jiménez-Díaz, Iñigo Angulo-Barturen, Robert T. Jacobs, Jeremy N. Burrows, Zachary D. Aron, Terry L. Bowlin and Sanjay A. Desai

Molecular Pharmacology September 2022, 102 (3) 172-182; DOI: https://doi.org/10.1124/molpharm.122.000549
Open Access
Mechanisms Underlying the Inhibition of KV1.3 Channel by Scorpion Toxin ImKTX58
Xu Zhang, Qianru Zhao, Fan Yang, Zhen Lan, Yi Li, Min Xiao, Hui Yu, Ziyi Li, Yongsheng Zhou, Yingliang Wu, Zhijian Cao and Shijin Yin

Molecular Pharmacology September 2022, 102 (3) 150-160; DOI: https://doi.org/10.1124/molpharm.121.000480
You have access
Screening and Identification of a Novel Anti–Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity
Jiaguo Wu, Jingyi Peng, Yangyihua Zhou, Ran Zhang, Zhihong Wang, Naijing Hu, Dingmu Zhang, Guiqi Quan, Yuanyu Wu, Jiannan Feng, Beifen Shen, Jian Zhao, Yan Zhang, Kaiming Yang and Longlong Luo

Molecular Pharmacology September 2022, 102 (3) 161-171; DOI: https://doi.org/10.1124/molpharm.121.000470
You have access
Michaelis-Menten Quantification of Ligand Signaling Bias Applied to the Promiscuous Vasopressin V2 Receptor
Franziska Marie Heydenreich, Bianca Plouffe, Aurélien Rizk, Dalibor Milić, Joris Zhou, Billy Breton, Christian Le Gouill, Asuka Inoue, Michel Bouvier and Dmitry B. Veprintsev

Molecular Pharmacology September 2022, 102 (3) 139-149; DOI: https://doi.org/10.1124/molpharm.122.000497
Open Access
Effects of Small Molecule Ligands on ACKR3 Receptors
Brittany E. Hopkins, Ikuo Masuho, Dongjun Ren, Iredia D. Iyamu, Wei Lv, Neha Malik, Kirill A. Martemyanov, Gary E. Schiltz and Richard J. Miller

Molecular Pharmacology September 2022, 102 (3) 128-138; DOI: https://doi.org/10.1124/molpharm.121.000295
Open Access
Molecular and Functional Characterization of GABA Receptor Subunits GRD and LCCH3 from Human Louse Pediculus Humanus Humanus
Omar Hashim, Claude L. Charvet, Berthine Toubaté, Aimun A.E. Ahmed, Nicolas Lamassiaude, Cédric Neveu, Isabelle Dimier-Poisson, Françoise Debierre-Grockiego and Catherine Dupuy

Molecular Pharmacology August 2022, 102 (2) 116-127; DOI: https://doi.org/10.1124/molpharm.122.000499
You have access
Lubiprostone is a Non-Selective Activator of cAMP-Gated Ion Channels and Chloride Channel Protein 2 (Clc-2) Has a Minor Role in its Prosecretory Effect in Intestinal Epithelial Cells
Apurva A. Oak, Tifany Chu, Pattareeya Yottasan, Parth D. Chhetri, Jie Zhu, J. Du Bois and Onur Cil

Molecular Pharmacology August 2022, 102 (2) 106-115; DOI: https://doi.org/10.1124/molpharm.122.000542
You have access
Effects of Inhibitors of SLC9A-Type Sodium-Proton Exchangers on Survival Motor Neuron 2 (SMN2) mRNA Splicing and Expression
Sambee Kanda, Emily Moulton and Matthew E.R. Butchbach

Molecular Pharmacology August 2022, 102 (2) 92-105; DOI: https://doi.org/10.1124/molpharm.122.000529
You have access
Resveratrol Binds Nuclear Receptor 4A1 (NR4A1) and Acts as an NR4A1 Antagonist in Lung Cancer Cells
Lei Zhang, Greg Martin, Kumaravel Mohankumar, Joshua Trae Hampton, Wenshe Ray Liu and Stephen Safe

Molecular Pharmacology August 2022, 102 (2) 80-91; DOI: https://doi.org/10.1124/molpharm.121.000481

Main menu

User menu

Search

More articles from Article

Pages

Navigate

More Information

ASPET's Other Journals